Jeito Capital co-dirige un financement de 104 millions d’euros pour Noema Pharma, une biopharma pour Noema Pharma, une biopharma ciblant les maladies graves du système nerveux central
07 mars 2023 04h00 HE
|
Jeito Capital
Jeito Capital co-dirige un financement de 104 millions d’euros pour Noema Pharma, une biopharma ciblant les maladies graves du système...
Paris, France Receives the 2023 Sustainable Transport Award for Progress on Accessibility, Sustainability, and Inclusion
06 févr. 2023 10h45 HE
|
ITDP
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The Institute for Transportation and Development Policy (ITDP) and the Sustainable Transport Award Committee are proud to announce Paris, France as the...
Jeito Capital renforce son soutien à Pulmocide en participant à un nouveau financement de 52 millions de dollars
06 déc. 2022 07h00 HE
|
Jeito Capital
Jeito Capital renforce son soutien à Pulmocide en participant à un nouveau financement de 52 millions de dollars Ce nouveau tour de table permettra d’accélérer le développement clinique et...
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer
22 nov. 2022 05h00 HE
|
Jeito Capital
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients...
Jeito Capital investit dans CatalYm Jeito Capital investit dans CatalYm société biopharmaceutique allemande spécialisée en immuno-oncologie
22 nov. 2022 05h00 HE
|
Jeito Capital
Jeito Capital investit dans CatalYm société biopharmaceutique allemande spécialisée en immuno-oncologie Jeito Capital co-dirige un financement de série C de 50 millions d'euros avec Brandon...
Smart Immune appoints world-class Clinical Advisory Board
21 nov. 2022 07h00 HE
|
Smart Immune
Smart Immune appoints world-class Clinical Advisory Board PARIS, France, November 21, 2022 – Smart Immune SAS, a clinical-stage biotechnology company developing ProTcell™, a pioneering new approach...
Coliving Startup Cohabs Joins Forces With Leading Real Estate Investors to Accelerate Growth
18 nov. 2022 15h46 HE
|
Cohabs
BRUSSELS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Cohabs, a Brussels-based company specializing in coliving, announces the entry into its capital of three new institutional investors: global real estate...
Jeito Capital réalise son 1er investissement aux Etats-Unis avec HI-Bio, biopharma spécialisée dans la médecine de précision des maladies auto-immunes
01 nov. 2022 09h05 HE
|
Jeito Capital
Jeito Capital réalise son 1er investissement aux Etats-Unis avec HI-Bio, biopharma spécialisée dans la médecine de précision des maladies...
Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases
01 nov. 2022 06h02 HE
|
Jeito Capital
Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with...
Big Idea Ventures’ latest cohort of startups enable scale and commercialization for the alternative protein industry
04 oct. 2022 08h00 HE
|
Big Idea Ventures, LLC
NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Big Idea Ventures, global leader in early-stage investments in the alternative protein sector, revealed its latest accelerator cohort today. ...